TSE:MFC

Manulife Financial (MFC.TO)

61.42
+1.50 (2.50%)
as of Sep 3, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconSep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mixture of opinions from analysts following its recent quarterly report, which showcased positive developments despite facing challenges such as a new tax on its products for mainland Chinese residents. The company is noted for its strong presence in Asia and steady growth in its wealth management segment, which remains a highlight in its long-term strategy. However, some experts express caution, labeling MFC as a bit overvalued relative to its earnings growth potential, currently trading over 2x book value. The financial landscape for insurers in Canada appears competitive, with both MFC and its peers like TD exhibiting relatively robust performance, yet the consensus leans toward a cautious approach due to market conditions. Overall, while MFC benefits from high dividends and solid asset management, uncertainties related to its exposure to market fluctuations warrant careful monitoring for potential entry points.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
BUY
Would buy at this price.
HOLD
Tremendously well managed. While diversified by geography and business line. Had a huge run and he questions if he should start trimming. Would look to buy on any weakness.
PAST TOP PICK
(A Top Pick Oct 2/06. Up 12.2%.) Still owns, but has scaled back because she thinks it is going to hit a wall for a while.
WAIT
Basically at a 52-week high. It's at the top of the multiple ranges and had a recent move. Would try to buy it back in the $38 range.
BUY
A great long-term play. Great growth in the US and China.
HOLD
A great company. Fairly reasonably priced, particularly compared to the banks. The premium that insurance companies in general have traded at has shrunk.
BUY
Moderately undervalued according to his valuations. Profit growth rate is better than the market average. Good yield. Stable earnings and ROE history. A relatively defensive interest-rate sensitive name.
TOP PICK
Likes their Hancock acquisition giving exposure to the US, but more important is their Asian positioning. Well run company.
BUY
Has a massively positive franchise in North America. The John Hancock acquisition has been well integrated. Likes their Asian exposure. Expects to see solid earnings growth in future.
BUY
In terms of using financial services to access greater Asian exposure this is a company you might want to consider.
HOLD
One of his favourite companies, but wouldn't be putting new money into it. On a relative valuation basis, Sun Life (SLF-T) is a little bit better buy at this point in time.
BUY
Of all the financials, this one has the nicest chart. The banks all did fairly well with 10%-20% returns. This one did not have the same returns and has some catching up to do. Had a number of bottoms from June on and they were always higher. Also had a pretty steady top with a nice breakout in November.
PAST TOP PICK
(A Top Pick Dec 28/05. Up 15.2%.) Still likes, but sold his holdings. If you want to be in this space, use Sun Life (SLF-T).
WAIT
Probably fully priced here and would let it consolidate. Good solid company. Expecting a market correction in the next 2 to 3 months.
BUY
Favourite life insurance company in North America. Best prospects to grow. Expect them to make a major acquisition in the US to further their growth. The big kicker is their far east operations.
Showing 1,831 to 1,845 of 2,284 entries